USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/19924
Title: Some aspects of contemporary heart failure pharmacotherapy
Authors: Chiriac, Valentina
Issue Date: 2012
Publisher: State Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Association, Scientific Association of Students and Young Doctors
Citation: CHIRIAC, Valentina. Some aspects of contemporary heart failure pharmacotherapy. In: MedEspera: the 4th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2012, p. 235.
Abstract: Introduction: Heart failure is a clinical syndrome with complex etiology, being the cause of hospitalization for one in three people on average, and the main cause of hospitalization for people aged over 65 years. The average incidence is 3.7% per year in men and 2.5% in women, depending on the age the incidence is doubling for each decade, starting from 45 to 75 years. The aim of the study was to analyze the fundamental principles of contemporary pharmacotherapy of heart failure. Materials and methods: Studying medical records of patients with heart failure of different genesis and severity. Statistical processing of data by using T-Student criterion. Results: We studied records of observation of 49 patients, of whom 21 (43%) women and 28 (57%) men; most patients aged over 51 years (93.9%). Study showed that disease prevalence increases rapidly age-matched. Of the 49 patients, 24.5% were disabled, 38.8% were retired, 6.1% were unemployed and only 30.61% were employed. Most people were suffering from heart failure for 2-5 years (75.5%). The analysis using the NYHA criteria reveals prevalence of functional classes II-III in 93.9% of patients. Laboratory findings detected substantial deviation of the following relevant indicators: cholesterol to 34,7% and LDL to 95,9%, dyslipidemia increases the risk of atherosclerotic complications. High values of sodium were detected in 10.2% patients, even though they have followed diuretic therapy. After analyzing observational records we established that contemporary pharmacotherapy c: heart failure includes a large variety of preparations, which are indicated with a wide frequency. The main medications: 1.converting enzyme inhibitors (lisinopril, ramipril) 39 (79.6%) to patients;2. (3- adreno-blockers (bisoprolol, metoprolol, carvedilol, betaxolol) to 29 (59.2%)patients; 3. diuretics (furosemide, torasemid, indapamide, spironolactone) to 48 (98%) patients;4. cardiac glycosides to 13 (26.5%) patients. Adjuvant medications include: organic nitrates-46,9%, calcium channel blockers-28,6%, antiaggregators-69,4%, anticoagulants-67,3%, cardioprotectors-49%, anxiolytics and sedative-49%, statins -25%. In therapy of concomitant diseases were used: antibiotics-36,7%, antimycotics-16,32%, vitamins and minerals-85,71%, peripheral vasodilators-28,6%, oral hypoglycaemic-12,2%, bronchodilators-14.3% and others. Conclusion: Contemporary treatment of heart failure is a complex and individualized process for each patient, including an extensive complex of preparations and pharmacological hygienic-dietary measures. Converting enzyme inhibitors, (3-adreno-blockers, diuretics and cardiac glycosides are essential for treatment.
metadata.dc.relation.ispartof: MedEspera: The 4th International Medical Congress for Students and Young Doctors, May 17-19, 2012, Chisinau, Republic of Moldova
URI: http://repository.usmf.md/handle/20.500.12710/19924
Appears in Collections:MedEspera 2012

Files in This Item:
File Description SizeFormat 
SOME_ASPECTS_OF_CONTEMPORARY_HEART_FAILURE_PHARMACOTHERAPY.pdf786.08 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback